SVA

Sinovac Biotech, Ltd
SVA

Overview Fund Activity
Delisted

SVA was delisted on the 22nd of February, 2019.

Back to rankings

27 hedge funds and large institutions have $83.7M invested in Sinovac Biotech, Ltd in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
-1
Holders Change %
-3.57%
% of All Funds
0.6%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
3
Increased
6
Reduced
6
Closed
3
Calls
$258K
Puts
$98K
Net Calls
+$160K
Net Calls Change
+$171K

Top Buyers

1
State Street
1
State Street
Massachusetts
$982K
2
RQS
2
Ramsey Quantitative Systems
Kentucky
$84K
3
Parallax Volatility Advisers
3
Parallax Volatility Advisers
California
$43K
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$236K
5
YMRC
5
Yorktown Management & Research Company
Virginia
$520K

Top Sellers

1
Invesco
1
Invesco
Georgia
$0
2
Renaissance Technologies
2
Renaissance Technologies
New York
$16.6M
3
NAH
3
Neumann Advisory (HK)
Hong Kong
$2.19M
4
SCP
4
Seizert Capital Partners
Michigan
$0
5
SIM
5
Spark Investment Management
New York
$201K
Name Holding Trade Value Shares
Change 		Shares
Change %
TRCT
26
Tower Research Capital (TRC)
New York
$2K +$448 +75 +29%
GWM
27
Geneos Wealth Management
Colorado
$1K – – –
Invesco
28
Invesco
Georgia
– -$619K -81,265 Closed
SCP
29
Seizert Capital Partners
Michigan
– -$275K -36,062 Closed
AAMU
30
Amundi Asset Management US
Massachusetts
– -$63K -8,300 Closed
1
2